Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.
Malignant melanoma is a life-threatening skin cancer increasingly diagnosed in the western world. In advanced disease the prognosis is grave. Growth and metastasis formation in melanomas are regulated by a network of cytokines, cytokine-receptors, and adhesion molecules. However, little is known abo...
Guardado en:
Autores principales: | Irina Mirkina, Emir Hadzijusufovic, Clemens Krepler, Mario Mikula, Diana Mechtcheriakova, Sabine Strommer, Alexander Stella, Erika Jensen-Jarolim, Christoph Höller, Volker Wacheck, Hubert Pehamberger, Peter Valent |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc58a81c66b84d88bfd1fe50d071f9fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli,Meysam, et al.
Publicado: (2019) -
Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
por: Yoon Sin Oh, et al.
Publicado: (2011) -
Increased NRG1-ErbB4 signaling in human symptomatic epilepsy
por: Jun-Ming Zhu, et al.
Publicado: (2017) -
Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize
por: Stephen R. Adams, et al.
Publicado: (2016) -
Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
por: Gillian Farnie, et al.
Publicado: (2013)